Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
20 companies screened for quality in a cheap part of the stock market
20 companies screened for quality in a cheap part of the stock market
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
Jim Cramer recommends five small-cap health-care stocks
Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.